Frequently Asked Questions about Ventyx Biosciences, Inc. (VTYX)

Name: Ventyx Biosciences, Inc. (VTYX) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Ventyx Biosciences, Inc. (VTYX) do?

Accepted Answer

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment...

Question 2

Is Ventyx Biosciences, Inc. (VTYX) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of VTYX reveals an Altman Z-Score of 25.09 and a Piotroski F-Score of 1/9. These metrics, combined with its 5-year revenue trend ($0.00B most recent), help investors decide if VTYX fits their risk profile.

Question 3

What is the current P/E ratio for VTYX?

Accepted Answer

As of the latest trading session, Ventyx Biosciences, Inc. (VTYX) has a trailing P/E ratio of -9.36.

Question 4

Who is the CEO of Ventyx Biosciences, Inc.?

Accepted Answer

The current Chief Executive Officer of Ventyx Biosciences, Inc. is Sheila K. Gujrathi.

Question 5

What was VTYX's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Ventyx Biosciences, Inc. reported annual revenues of $0.00B (2024), $0.00B (2023), $0.00B (2022), $0.00B (2021), $0.00B (2020) respectively.

Question 6

Does VTYX pay a dividend?

Accepted Answer

Ventyx Biosciences, Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does VTYX have?

Accepted Answer

In its latest reporting period, Ventyx Biosciences, Inc. generated $-0.13B in Free Cash Flow against a total debt load of $0.01B.

Question 8

What is the Price-to-Book (P/B) ratio of Ventyx Biosciences, Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Ventyx Biosciences, Inc. (VTYX) is currently 5.22.

Question 9

What is the Price-to-Sales (P/S) ratio of VTYX?

Accepted Answer

Based on trailing twelve-month data, Ventyx Biosciences, Inc. (VTYX) trades at a Price-to-Sales (P/S) ratio of 0.00.

Question 10

What is Ventyx Biosciences, Inc.'s Return on Equity (ROE)?

Accepted Answer

Ventyx Biosciences, Inc. (VTYX) has a Return on Equity (ROE) of -48.11%, representing its profitability relative to shareholder equity.

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2024-12	-130.9M	22.9M	-241K	-131.1M	-154M
2023-12	-166.5M	28.6M	-514K	-167M	-195.6M
2022-12	-98.8M	16.6M	-275K	-99M	-115.6M
2021-12	-38.7M	2.7M	-262K	-38.9M	-41.6M
2020-12	-6.2M	45K	0	-6.2M	-6.2M